Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Peter Libby MD
Peter Libby MD Advisory Board
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
See All Experts
Published in Cardiology

Journal Scan / Research · December 08, 2024

Flecainide for Atrial Arrhythmia Prevention After Patent Foramen Ovale Closure

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Giselle Suero-Abreu MD, PhD, MSc

Circulation
Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial
Circulation 2024 Nov 19;150(21)1659-1668, M Hauguel-Moreau, P Guedeney, C Dauphin, V Auffret, JM Clerc, E Marijon, M Elbaz, P Aldebert, F Beygui, W Abi Khalil, A Da Costa, JC Macia, S Elhadad, G Cayla, X Iriart, M Laredo, T Rolland, Y Temmar, ME Gheorghiu, D Brugier, J Silvain, N Hammoudi, G Duthoit, A Diallo, E Vicaut, G Montalescot

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated